Expression Profiling Elucidates a Molecular Gene Signature for Pulmonary Hypertension in Sarcoidosis
Sunit Singla(University of Illinois Chicago), Roberto F. Machado(University of Maryland, Baltimore), Kamran Javaid(University of Illinois Chicago), Joe G. N. Garcia(Scripps Research Institute), Tong Zhou(Jiangsu Academy of Agricultural Sciences), Nancy G. Casanova(University of Arizona), Shwu‐Fan Ma(University of Chicago), Wei Zhang(Hebei Medical University), Michael S. Wade(University of Illinois Chicago), Nadera Sweiss(University of Illinois Chicago), Taimur Abbasi(Harvard University), Imre Noth(University of Virginia)
Cited by 13
Related Papers
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis
|JAMA|2013|456
PD-1 up-regulation on CD4 <sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
|Science Translational Medicine|2018|364
<i>TOLLIP</i> , <i>MUC5B</i> , and the Response to <i>N</i> -Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2015|358